close
MENU
Business
3 mins to read

Pacific Edge taps investors for cash again

The US market is proving a hard nut to crack for the cancer diagnostics firm

Tim Hunter
Thu, 29 Nov 2018

Cancer diagnostics company Pacific Edge is going back to shareholders for more capital as it continues to burn through cash in its quest for a US breakthrough.

After its shares were placed in a trading halt today Pacific Edge announced a share placement to raise $7 million at 35c a share,

Want to read more? It's easy.

Choose your best value subscription option

Student

Exclusive offer for uni students studying at a New Zealand university (valued at $499).
Individual
Group membership
NBR Marketplace
NZ Aviation News

Yearly Premium Online Subscription

NZ$499.00 / yearly

Monthly Premium Online Subscription

NZ$44.95 / monthly

Smartphone Only Subscription

NZ$24.95 / monthly

Premium Group Membership 10 Users

NZ$350+GST / monthly

$35 per user - Pay by monthly credit card debit

Premium Group Membership 20 Users

NZ$600+GST / monthly

$30 per user - Pay by monthly credit card debit

Premium Group Membership 50 Users

NZ$1250+GST / monthly

$25 per user - Pay by monthly credit card debit

Premium Group Membership 100 Users

NZ$1875+GST / monthly

$18.75 per user - Pay by monthly credit card debit

Yearly Premium Online Subscription + NBR Marketplace

NZ$499.00 / yearly

Aviation News - Monthly

NZ$14.95 / monthly

Already have an account? Login
Tim Hunter
Thu, 29 Nov 2018
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Pacific Edge taps investors for cash again
Business,
77457